MICS IOLs better than conventional IOLs

Article

Microincision cataract surgery (MICS) intraocular lenses (IOLs) provide better patient outcomes, which are more like refractive surgery in terms of reduced postoperative astigmatism and minimal induced aberrations, according to a French study.

Microincision cataract surgery (MICS) intraocular lenses (IOLs) provide better patient outcomes, which are more like refractive surgery in terms of reduced postoperative astigmatism and minimal induced aberrations, according to a French study.

Danielle Deidier from Clinic St Vincent, Toulon, France conducted a prospective study of 400 eyes undergoing bimanual MICS. Three hundred eyes received the Akreos MI60, 50 eyes received the Microslim (Physiol) and 50 the Quatrix (Corneal) through a 1.7 mm incision. Aberrometry and higher order aberrations were measured preoperatively and at one week, one month and three months postoperatively.

All three lenses demonstrated good stability within the capsular bag, in addition to good uncorrected visual acuity and best corrected visual acuity results. Low levels of induced astigmatism were recorded and endothelial cell counts were also good.

It was the conclusion of this study that MICS IOLs offer better patient outcomes than conventional lenses.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.